Abstract
BackgroundPreclinical studies have firmly established the CD47-signal-regulatory protein (SIRP)α axis as a myeloid immune checkpoint in cancer, and this is corroborated by available evidence from the first clinical studies with...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have